- Report
- March 2024
- 188 Pages
Global
From €3270EUR$3,374USD£2,801GBP
€3633EUR$3,749USD£3,112GBP
- Report
- April 2024
- 182 Pages
Global
From €4797EUR$4,950USD£4,109GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1454EUR$1,500USD£1,245GBP
- Report
- February 2024
- 184 Pages
Global
From €4749EUR$4,900USD£4,067GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1938EUR$2,000USD£1,660GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1938EUR$2,000USD£1,660GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1938EUR$2,000USD£1,660GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1454EUR$1,500USD£1,245GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1938EUR$2,000USD£1,660GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1938EUR$2,000USD£1,660GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1211EUR$1,250USD£1,038GBP
- Report
- May 2023
- 73 Pages
Global
From €3500EUR$3,869USD£3,103GBP
- Report
- April 2023
- 117 Pages
Global
From €4603EUR$4,750USD£3,943GBP
- Report
- January 2022
- 200 Pages
Global
From €7268EUR$7,500USD£6,225GBP
- Report
- January 2022
- 200 Pages
Global
From €7268EUR$7,500USD£6,225GBP
- Report
- January 2022
- 200 Pages
Global
From €7268EUR$7,500USD£6,225GBP
- Report
- January 2022
- 200 Pages
Global
From €7268EUR$7,500USD£6,225GBP
- Report
- January 2022
- 200 Pages
Global
From €7268EUR$7,500USD£6,225GBP
- Report
- January 2022
- 60 Pages
Global
From €3828EUR$3,950USD£3,279GBP
- Report
- January 2022
- 60 Pages
Global
From €3828EUR$3,950USD£3,279GBP
The Pneumonia Drug market is a subset of the larger Respiratory Drugs market. It includes drugs used to treat bacterial, viral, and fungal pneumonia, as well as other respiratory infections. These drugs are typically administered orally, intravenously, or intramuscularly, depending on the severity of the infection. Commonly prescribed drugs include antibiotics, antivirals, antifungals, and corticosteroids. In addition, some drugs are used to reduce inflammation and improve breathing.
The Pneumonia Drug market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck, Sanofi, AstraZeneca, and Novartis. Show Less Read more